145 related articles for article (PubMed ID: 7846198)
1. Effects of ipsapirone in healthy subjects: a dose-response study.
Kahn RS; Trestman R; Lawlor BA; Gabriel S; Davidson M; Siever L
Psychopharmacology (Berl); 1994 Feb; 114(1):155-60. PubMed ID: 7846198
[TBL] [Abstract][Full Text] [Related]
2. Complex effects of age and gender on hypothermic, adrenocorticotrophic hormone and cortisol responses to ipsapirone challenge in normal subjects.
Gelfin Y; Lerer B; Lesch KP; Gorfine M; Allolio B
Psychopharmacology (Berl); 1995 Aug; 120(3):356-64. PubMed ID: 8524984
[TBL] [Abstract][Full Text] [Related]
3. Blunted 5-HT1A-receptor agonist-induced corticotropin and cortisol responses after long-term ipsapirone and fluoxetine administration to healthy subjects.
Berlin I; Warot D; Legout V; Guillemant S; Schöllnhammer G; Puech AJ
Clin Pharmacol Ther; 1998 Apr; 63(4):428-36. PubMed ID: 9585797
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine response to meta-chlorophenylpiperazine and ipsapirone in relation to anxiety and aggression.
Klaassen T; Riedel WJ; van Praag HM; Menheere PP; Griez E
Psychiatry Res; 2002 Dec; 113(1-2):29-40. PubMed ID: 12467943
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the alpha 2-adrenoceptor blocking properties of buspirone and ipsapirone in healthy subjects. Relationship with the plasma concentration of the common metabolite 1-(2-pyrimidinyl)-piperazine.
Berlin I; Chalon S; Payan C; Schöllnhammer G; Cesselin F; Varoquaux O; Puech AJ
Br J Clin Pharmacol; 1995 Mar; 39(3):243-9. PubMed ID: 7619663
[TBL] [Abstract][Full Text] [Related]
6. Effects of m-chlorophenylpiperazine in normal subjects: a dose-response study.
Kahn RS; Wetzler S; Asnis GM; Kling MA; Suckow RF; van Praag HM
Psychopharmacology (Berl); 1990; 100(3):339-44. PubMed ID: 2156278
[TBL] [Abstract][Full Text] [Related]
7. 5-HT1A receptor-effector system responsivity in panic disorder.
Lesch KP; Wiesmann M; Hoh A; Müller T; Disselkamp-Tietze J; Osterheider M; Schulte HM
Psychopharmacology (Berl); 1992; 106(1):111-7. PubMed ID: 1346719
[TBL] [Abstract][Full Text] [Related]
8. Serotonin1A receptor activation by flesinoxan in humans. Body temperature and neuroendocrine responses.
Seletti B; Benkelfat C; Blier P; Annable L; Gilbert F; de Montigny C
Neuropsychopharmacology; 1995 Oct; 13(2):93-104. PubMed ID: 8597527
[TBL] [Abstract][Full Text] [Related]
9. Daily administration of m-chlorophenylpiperazine to healthy human volunteers rapidly attenuates many of its behavioral, hormonal, cardiovascular and temperature effects.
Benjamin J; Greenberg BD; Murphy DL
Psychopharmacology (Berl); 1996 Sep; 127(2):140-9. PubMed ID: 8888380
[TBL] [Abstract][Full Text] [Related]
10. Cortisol, hypothermic, and behavioral responses to ipsapirone in patients with bipolar depression and normal controls.
Shiah IS; Yatham LN; Lam RW; Tam EM; Zis AP
Neuropsychobiology; 1998; 38(1):6-12. PubMed ID: 9701716
[TBL] [Abstract][Full Text] [Related]
11. Effects of divalproex sodium on 5-HT1A receptor function in healthy human males: hypothermic, hormonal, and behavioral responses to ipsapirone.
Shiah IS; Yatham LN; Lam RW; Zis AP
Neuropsychopharmacology; 1997 Dec; 17(6):382-90. PubMed ID: 9397426
[TBL] [Abstract][Full Text] [Related]
12. Effects of short-term administration of valproate on serotonin-1A and dopamine receptor function in healthy human subjects.
Delva NJ; Brooks DL; Franklin M; al-Said K; Hawken ER; Merali Z; Lawson JS; Ravindran AV
J Psychiatry Neurosci; 2002 Nov; 27(6):429-37. PubMed ID: 12491576
[TBL] [Abstract][Full Text] [Related]
13. Long-term fluoxetine treatment decreases 5-HT1A receptor responsivity in obsessive-compulsive disorder.
Lesch KP; Hoh A; Schulte HM; Osterheider M; Müller T
Psychopharmacology (Berl); 1991; 105(3):415-20. PubMed ID: 1686817
[TBL] [Abstract][Full Text] [Related]
14. Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects.
Strassman RJ; Qualls CR
Arch Gen Psychiatry; 1994 Feb; 51(2):85-97. PubMed ID: 8297216
[TBL] [Abstract][Full Text] [Related]
15. Effects of antiglucocorticoid treatment on 5-HT1A function in depressed patients and healthy subjects.
Price LH; Cappiello A; Malison RT; McDougle CJ; Pelton GH; Schöllnhammer G; Heninger GR
Neuropsychopharmacology; 1997 Oct; 17(4):246-57. PubMed ID: 9326749
[TBL] [Abstract][Full Text] [Related]
16. Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects.
Broocks A; Meyer T; Gleiter CH; Hillmer-Vogel U; George A; Bartmann U; Bandelow B
Psychopharmacology (Berl); 2001 May; 155(3):234-41. PubMed ID: 11432685
[TBL] [Abstract][Full Text] [Related]
17. The effects of gepirone on neuroendocrine function and temperature in humans.
Anderson IM; Cowen PJ; Grahame-Smith DG
Psychopharmacology (Berl); 1990; 100(4):498-503. PubMed ID: 2157231
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the neuro-endocrinological and temperature effects of DU 29894, flesinoxan, sulpiride and haloperidol in normal volunteers.
de Koning P; de Vries MH
Br J Clin Pharmacol; 1995 Jan; 39(1):7-14. PubMed ID: 7756102
[TBL] [Abstract][Full Text] [Related]
19. Endocrinological effects of high-dose Hypericum perforatum extract WS 5570 in healthy subjects.
Schüle C; Baghai T; Sauer N; Laakmann G
Neuropsychobiology; 2004; 49(2):58-63. PubMed ID: 14981335
[TBL] [Abstract][Full Text] [Related]
20. Hormonal and temperature responses to flesinoxan in normal volunteers: an antagonist study.
Pitchot W; Wauthy J; Legros JJ; Ansseau M
Eur Neuropsychopharmacol; 2004 Mar; 14(2):151-5. PubMed ID: 15013031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
